Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H18N4O |
Molecular Weight | 270.3296 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N[C@@H]1CN2CCC1CC2)C3=NNC4=C3C=CC=C4
InChI
InChIKey=TXCYUSKWBHUVEP-CYBMUJFWSA-N
InChI=1S/C15H18N4O/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18)/t13-/m1/s1
Molecular Formula | C15H18N4O |
Molecular Weight | 270.3296 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Facinicline (MEM-63908 or R-4996) is a selective nicotinic alpha-7 receptor (α7nAChR) partial agonist. It also has properties of a serotonin 3 receptor antagonist. It has hydrochloride form: RG3487 (formerly MEM3454). Facinicline enhances DA efflux by nAChR stimulation, whereas ACh efflux is primarily mediated via 5-HT3 receptor antagonism. It improves cognition and sensorimotor gating in rodents. It has been tested in Alzheimer's disease and cognitive symptoms of schizophrenia.
CNS Activity
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 22:10:38 GMT 2023
by
admin
on
Fri Dec 15 22:10:38 GMT 2023
|
Record UNII |
6A6FX0J03K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166923
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
677306-35-3
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
DTXSID90218011
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
DB05586
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
9970357
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
6A6FX0J03K
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
300000034250
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY | |||
|
9456
Created by
admin on Fri Dec 15 22:10:38 GMT 2023 , Edited by admin on Fri Dec 15 22:10:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |